Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian
The best umbrellas in the UK for staying dry in the wind and rain – tested on a 517m hilltop
4/11/2025
Gopichand Hinduja, head of Britain’s richest family, dies aged 85
4/11/2025
The mind-boggling valuations of AI companies
4/11/2025
The art of the possible : the Nottingham art gallery being run by citizens’ assembly
4/11/2025
Football Manager 26 review –a modern sim for the modern game
4/11/2025
Rise of the ‘porno-trolls’ : how one porn platform made millions suing its viewers
4/11/2025